GMP for Cannabis – what you need to know - Live Online Conference
19/20 May 2026
Course No. 21905
Speakers
Dr Ingrid Walther
Pharma Consulting Walther, Chair of the ECA Cannabis Working Group
Dr Rainer Gnibl
GMP Inspector
Luis Meirinhos-Soares
Former GMP Inspector at INFARMED, ECA Cannabis Working Group
Dr Georgia Tossi
Linnea, ECA Cannabis Working Group
Tina Cacanoska
PharmaRolly, ECA Cannabis Working Group
Dr Viviana Braude
Cronos Israel, ECA Cannabis Working Group
Dr Anne Wolf
German Cannabis Agency, BfArM (invited)
Dr David Surjo
GOC NEXUS
Joaquin Dell’Acqua
Agronomist
Note: All times mentioned are CEST.
Objectives
Medical cannabis has been meanwhile permitted for prescription in several countries around the world, causing a need for producers supplying pharmacists and physicians with the newly legalized drug. But what qualifies as medical grade cannabis? And which aspects have to be considered for CBD-Products? This conference will give you an overview of all relevant GACP/GMP requirements and regulatory aspects for medical cannabis and CBD-Products.
Background
Medical cannabis products must comply with the relevant requirements laid down under Medicinal and Narcotics Law. The relevant requirements based on the underlying legal framework (including Pharmacopoeias) and the corresponding EU GMP/ GDP and GACP guidelines must be complied with when supplying medical cannabis to the EU market.
The EU GMP inspectorates are responsible for issuing manufacturing and import licenses or “GMP Certificates”. Thus, they will perform inspections at the sites of manufacturers who apply for these certificates and licenses. Meanwhile, European pharmacopoeial (Ph. Eur.) monographs describing the quality requirements for cannabis flower (API or for direct prescription to patients) and for CBD have been established and implemented. However, questions still arise, because:
There is currently no harmonized “EU GMP Cannabis Standard” or “Global GMP Cannabis Standard” available for medical cannabis (API / Herbal Medicinal Product).
The Ph. Eur. Cannabis Flower and CBD monographs are currently not harmonized with the corresponding USP (draft) monographs.
Regarding quality requirements for Cannabis Extracts (Herbal Drug Preparation) only national monographs exist so far.
Thus, national regulations, guidelines and pharmacopoeial monographs will have to be followed and applied in addition to EUGMP.
Target Group
This Live Online Conference addresses specific GMP aspects to consider for Growers, Manufacturers, Start-Ups, Suppliers, Importers, Wholesalers, QPs and QA/QC personnel involved in Cannabis production and release. The topics provided are also of interest for GACP/GMP/GDP Inspectors responsible for issuing a "GMP certificate" or manufacturers/import license.
Date & Technical Requirements
Date of the Live Online Conference Tuesday, 19 May 2026, 12.00 to approx. 18.00 h Wednesday, 20 May 2026, 10.00 to approx. 18.00 h All times mentioned are CEST.
Technical Requirements We use Webex for our live online training courses and webinars. At www.gmp-compliance.org/training/online-trainingtechnical-information you will find all the information you need to participate in our events and you can check if your System meets the necessary requirements to participate. If the installation of browser extensions is not possible due to your rights in the IT system, please contact your IT department. Webex is a standard nowadays and the necessary installation is fast and easy.
Testimonials
Seminar Programme as PDF